EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Urinary Small Extracellular Vesicle DNA as a Biomarker for the Non‐Invasive Diagnosis of Bladder Cancer

Tao Wang, Xin Liao, Jiyang Zhang, Xiaoya Xu, Wei Zhang, Xinlin Chen, Xinyu Zhai, Tongtong Zhang, Xiangyang Zhan, Xingyu Mu, Dadong Zhang, Jian Chen und 2 weitere

Cancer Science · 2026

DOI: 10.1111/cas.70455 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2026. Verfasst von Tao Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Surgical Institute of Integrative Medicine, Surgical Institute, Shanghai Key Laboratory of Traditional Chinese Clinical Medici…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Extracellular Vesicles, Urinary Bladder Neoplasms. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: 2024 Shanghai Eastern Elite Talents Program, Top-Tier Project, National Natural Science Foundation for Young Scholars of China, Open Competition Project of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Existing diagnostic technologies for bladder cancer (BC) suffer from low sensitivity, low specificity, or a lack of validation. Therefore, validated, non‐invasive diagnostic biomarkers with high sensitivity and specificity for early detection of BC are needed to complement and improve upon the limitations of existing diagnostic methods. We used low‐pass whole genome sequencing (LP‐WGS) technology to detect copy number variations (CNVs) in small extracellular vesicle (sEV) DNA isolated from urine samples of patients. Based on these results, we constructed and validated a diagnostic model to differentiate between benign and malignant bladder lesions. We conducted a receiver operating characteristic analysis and calculated the area under the curve (AUC) to evaluate the performance of the diagnostic model. The urine sEV‐DNA LP‐WGS data revealed CNV differences between benign and malignant samples. The diagnostic model achieved an AUC of 0.953, a sensitivity of 86.7%, and a specificity of 100% in the training cohort and an AUC of 0.985, a sensitivity of 90%, and a specificity of 100% in the validation cohort. Even at the lowest coverage depth of 0.01X, the performance of the diagnostic model remained relatively robust. Notably, the performance of this diagnostic model surpassed that of the biomarker neuron‐specific enolase (sensitivity: 85.7% vs. 64.3%; specificity: 100% vs. 87.5%) and urinary cytology (sensitivity: 100% vs. 66.7%; specificity: 100% vs. 94.1%). Our study demonstrates that urine sEV‐DNA exhibits high discriminatory power in distinguishing between benign and malignant bladder lesions, making it a promising tool for auxiliary diagnosis of BC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorExtracellular VesiclesUrinary Bladder NeoplasmsHumansFemaleMaleDNA Copy Number VariationsAgedSensitivity and SpecificityMiddle AgedROC CurveWhole Genome SequencingExtrachromosomal DNAEarly Detection of Cancer

Stichwörter der Autor:innen

bladder cancernon‐invasive diagnostic biomarkerssmall extracellular vesicle DNAwhole‐genome sequencing

Substanzen

Biomarkers, TumorExtrachromosomal DNA

Autor:innen und Institutionen

  • Department of Urology, Surgical Institute of Integrative Medicine, Surgical Institute, Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shuguang Hospital, Shanghai University of Traditional Chinese Medi…
  • Department of Clinical and Translational Medicine, 3D Medicines Inc., Shanghai, China.
  • Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Urology, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, China.

ORCID-Profile: Dongliang Xu, Mingyue Tan

Förderung

  • 2024 Shanghai Eastern Elite Talents Program, Top-Tier Project
  • National Natural Science Foundation for Young Scholars of China
  • Open Competition Project of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Zitieren

APA

Wang, T., Liao, X., Zhang, J., Xu, X., Zhang, W., Chen, X., Zhai, X., Zhang, T., Zhan, X., Mu, X., Zhang, D., Chen, J., Xu, D., & Tan, M. (2026). Urinary Small Extracellular Vesicle DNA as a Biomarker for the Non‐Invasive Diagnosis of Bladder Cancer. Cancer Science. https://doi.org/10.1111/cas.70455

Vancouver

Wang T, Liao X, Zhang J, Xu X, Zhang W, Chen X, et al. Urinary Small Extracellular Vesicle DNA as a Biomarker for the Non‐Invasive Diagnosis of Bladder Cancer. Cancer Science. 2026. doi:10.1111/cas.70455

BibTeX
@article{Wang2026,
  author = {Wang, Tao and Liao, Xin and Zhang, Jiyang and Xu, Xiaoya and Zhang, Wei and Chen, Xinlin and Zhai, Xinyu and Zhang, Tongtong and Zhan, Xiangyang and Mu, Xingyu and Zhang, Dadong and Chen, Jian and Xu, Dongliang and Tan, Mingyue},
  title = {Urinary Small Extracellular Vesicle DNA as a Biomarker for the Non‐Invasive Diagnosis of Bladder Cancer},
  journal = {Cancer Science},
  year = {2026},
  doi = {10.1111/cas.70455}
}
Kostenlos starten →